Global Therapeutic BCG Vaccines Market Estimated to Grow with a CAGR of 4.5% During the Forecast Period, 2019-2025 - ResearchAndMarkets.com

DUBLIN--()--The "Therapeutic BCG Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global therapeutic BCG vaccines market to grow with a CAGR of 4.5% over the forecast period from 2019-2025.
The report on the global therapeutic BCG vaccines market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on therapeutic BCG vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on therapeutic BCG vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global therapeutic BCG vaccines market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global therapeutic BCG vaccines market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rising prevalence of tuberculosis
  • Rising awareness programs for immunization

2) Restraints

  • Side effects such as swollen lymph nodes, frequent urination

3) Opportunities

  • Increasing demand from various underdeveloped and developing regions
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the therapeutic BCG vaccines market.

2. Complete coverage of all the segments in the therapeutic BCG vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2025.

3. Comprehensive analysis of the companies operating in the global therapeutic BCG vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Therapeutic BCG Vaccines Market Highlights

2.2. Therapeutic BCG Vaccines Market Projection

2.3. Therapeutic BCG Vaccines Market Regional Highlights

3. Global Therapeutic BCG Vaccines Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Type

3.4.2. Growth Matrix Analysis by Demographics

3.4.3. Growth Matrix Analysis by End User

3.4.4. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Therapeutic BCG Vaccines Market

4. Therapeutic BCG Vaccines Market Macro Indicator Analysis

5. Global Therapeutic BCG Vaccines Market by Type

5.1. Immune BCG

5.2. Therapy BCG

6. Global Therapeutic BCG Vaccines Market by Demographics

6.1. Pediatrics

6.2. Adults

7. Global Therapeutic BCG Vaccines Market by End User

7.1. Hospitals

7.2. Clinics

7.3. Other End Users

8. Global Therapeutic BCG Vaccines Market by Region 2019-2025

8.1. North America

8.1.1. North America Therapeutic BCG Vaccines Market by Type

8.1.2. North America Therapeutic BCG Vaccines Market by Demographics

8.1.3. North America Therapeutic BCG Vaccines Market by End User

8.1.4. North America Therapeutic BCG Vaccines Market by Country

8.2. Europe

8.3. Asia-Pacific

8.4. RoW

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Therapeutic BCG Vaccines Market

9.2. Companies Profiled

9.2.1. Sanofi Pasteur

9.2.2. Merck & Co., Inc.

9.2.3. Serum Institute of India Private Limited

9.2.4. InterVax Ltd.

9.2.5. Green Signal Bio Pharma Pvt Ltd

9.2.6. Statens Serum Institut

9.2.7. China National Biotec Group

9.2.8. Japan BCG Laboratory

9.2.9. Other companies

For more information about this report visit https://www.researchandmarkets.com/r/sd4s7l

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines